GlaxoSmithkline Consumer Healthcare standalone net profit rises 20.43% in the March 2018 quarter

Sales rise 6.96% to Rs 1179.58 crore

Net profit of GlaxoSmithkline Consumer Healthcare rose 20.43% to Rs 211.81 crore in the quarter ended March 2018 as against Rs 175.88 crore during the previous quarter ended March 2017. Sales rose 6.96% to Rs 1179.58 crore in the quarter ended March 2018 as against Rs 1102.81 crore during the previous quarter ended March 2017.

For the full year,net profit rose 6.61% to Rs 700.10 crore in the year ended March 2018 as against Rs 656.67 crore during the previous year ended March 2017. Sales rose 8.15% to Rs 4316.51 crore in the year ended March 2018 as against Rs 3991.28 crore during the previous year ended March 2017.

ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales1179.581102.81 7 4316.513991.28 8 OPM %21.2019.77 -20.4621.00 - PBDT333.43287.16 16 1138.731074.59 6 PBT318.89269.46 18 1074.361010.41 6 NP211.81175.88 20 700.10656.67 7

Powered by Capital Market - Live News